Blog
RSS FeedPosted by Michael Wonder on 14 Apr 2021
AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
14 April 2021 - EMA continues to monitor very rare blood clots with low blood platelets that occurred after vaccination ...
Posted by Michael Wonder on 14 Apr 2021
COVID-19 vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues
14 April 2021 - As announced last week, EMA’s safety committee (PRAC) is reviewing very rare cases of unusual blood clots ...
Posted by Michael Wonder on 10 Apr 2021
Johnson & Johnson COVID-19 vaccine under review by EMA over blood clots
10 April 2021 - Europe’s drug regulator says it is reviewing rare blood clots in four people in the United States ...
Posted by Michael Wonder on 08 Apr 2021
With millions vaccinated, rare side-effects of jabs are emerging
7 April 2021 - Sorting signal from noise. ...
Posted by Michael Wonder on 07 Apr 2021
AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
7 April 2021 - EMA confirms overall benefit-risk remains positive. ...
Posted by Michael Wonder on 31 Mar 2021
AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues
31 March 2021 - EMA’s safety committee (PRAC) is meeting today in the context of its ongoing review of very ...
Posted by Michael Wonder on 30 Mar 2021
Germany to restrict AstraZeneca use in under-60s over clots
30 March 2021 - German health officials have agreed to restrict the use of AstraZeneca’s coronavirus vaccine in people under 60, ...
Posted by Michael Wonder on 25 Mar 2021
COVID-19 Vaccine AstraZeneca – update on ongoing evaluation of blood clot cases
25 March 2021 - Last week, EMA’s safety committee, PRAC, concluded its preliminary review of cases of blood clots, including very ...
Posted by Michael Wonder on 18 Mar 2021
COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
18 March 2021 - EMA’s safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people ...
Posted by Michael Wonder on 17 Mar 2021
Europe’s vaccine suspension may be driven as much by politics as science
16 March 2021 - Once it became clear Germany was pausing, the pressure mounted on other governments to hold off as ...
Posted by Michael Wonder on 16 Mar 2021
AstraZeneca vaccine fears may be more deadly than any side effect
16 March 2021 - In Europe, vaccination against COVID-19 is off to a worryingly slow start. Just 11 doses for every ...
Posted by Michael Wonder on 16 Mar 2021
Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues
16 March 2021 - EMA’s safety committee (PRAC) made further progress today in its detailed evaluation of cases of blood clots, ...
Posted by Michael Wonder on 15 Mar 2021
Multiple countries pause AstraZeneca vaccine use
16 March 2021 - Germany, France and Italy are the latest countries to have suspended the AstraZeneca vaccine over blood clotting ...
Posted by Michael Wonder on 15 Mar 2021
EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events
15 March 2021 - Several authorities responsible for national vaccine campaigns in EU countries have temporarily paused vaccination with COVID-19 Vaccine ...
Posted by Michael Wonder on 11 Mar 2021
COVID-19 vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks
11 March 2021 - The EMA is aware that the Danish Health Authority has paused its vaccination campaign with COVID-19 ...